CPE and Alzheimer disease: Western blot determination of the ratio of LC3II/LC3I showed that it was decreased in 3xTg-AD compared to non-Tg mice, and increased in 3xTg-AD mice with AAV-NF-α1/CPE and AAV-NF-α1/CPE-E342Q treatment (Fig. 7C).